Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Ultrasound Stimulation as a Neuromodulation Therapy for Craving and Relapse Behaviors in Alcohol Use Disorder.

NCT06867224 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT06867224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06867224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Ultrasound Stimulation as a Neuromodulation Therapy for Craving and Relapse Behaviors in Alcohol Use Disorder.
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 20, 2025
Completion date
January 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), transcranial ultrasound stimulation